Vaccinomics to Design a Multiepitope Vaccine against Legionella pneumophila

Table 2

Final CTL selected epitopes for the construction of vaccine against L. pneumophila.

Epitope	Protein	Alleles	Position	Antigenicity	Immunogenicity
CSEIDPKADY	YARHG domain-containing protein	HLA-A01:01; HLA-A30:02	4-35	1.4910	0.0202
FPPLATVNIH	YARHG domain-containing protein	HLA-B53:01; HLA-B35:01	3-38	1.1473	0.1723
FSFLFLFSTFTF	Uncharacterized protein	HLA-A23:01; HLA-A24:02; HLA-B46:01; HLA-B15:02; HLA-A29:02; HLA-C07:02; HLA-B58:01; HLA-B35:01; HLA-B57:01	1-6	1.8775	0.24096
NVSGRTLRLDLW	Uncharacterized protein	HLA-B58:01	1-49	2.4487	0.11
KPQWLLSLGYEY	SPOR domain-containing protein	HLA-A29:02; HLA-A30:02; HLA-B35:01	6-27	1.1161	0.07907
GFSVDVRMGEVE	Metalloprotease PmbA	HLA-B46:01; HLA-C08:02; HLA-C15:02	1-47	1.9821	0.06956
PFFAPVPWEADL	Peptide ABC transporter substrate-binding protein	HLA-B35:03; HLA-C03:03; HLA-C07:02	5-10	1.0915	0.4519